Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Alexander Ruebben , Juergen Boeing , Norbert Weiss Added: 3 years ago
The Elutax© is a rapid exchange percutaneous transluminal coronary angioplasty (PTCA) catheter. There are two versions: one for standard-size coronary and small peripheral vessels (Elutax 2nd Generation) and one for small coronary vessels (Elutax SV). The Aachen Resonance® Elutax drug-eluting balloon family was developed especially for coronary arteries and venous bypass as well as for small… View more

Imaging & Diagnostics

Intervention
Author(s): Alexander Ruebben , Juergen Boeing , Norbert Weiss Added: 3 years ago
More drug-eluting balloons are entering the market. However, it is difficult for the user to understand the differences between these devices. This article aims to increase understanding of these devices, from the point of view of the manufacturer and for benefit of the user. The differences of the balloon coating can be found: in the loading dose; in the excipient; and in the way the… View more

MI/ACS

Intervention
SMART Trial
Author(s): Didier Tchétché Added: 1 week ago
Dr Didier Tchétché (Clinique Pasteur, Toulouse, FR) joins us to discuss findings from the SMART Trial.This prospective, multi-centre, randomised controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli and severe symptomatic aortic stenosis. At… View more

Intervention
Balloon Pulmonary Angioplasty: State of the Art
Author(s): John G Coghlan , Alexander MK Rothman , Stephen P Hoole Added: 3 years ago

Prevention & Chronic Conditions

Intervention
Author(s): John Jose , Gert Richardt , Mohamed Abdel-Wahab Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has undergone tremendous technological advancements since the first successful implantation in 2002 for symptomatic severe aortic valve stenosis (AS).1 It is currently considered as the standard of care for severe AS patients who have high surgical risk or may be deemed unsuitable for surgery.2 Broadly, there are two main categories of transcatheter… View more

Vascular Disease and Surgery

Intervention
Author(s): Ferry van der Linde Added: 3 years ago
Recently, a novel type of interventional device has become available on the market: the drug-eluting balloon (DEB). The established performance of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter has been combined with the proven efficacy of antiproliferative drugs. The usefulness of DEBs has been established,1–6 especially for treating in-stent restenosis (ISR), when… View more

Prevention & Chronic Conditions
TCT 23: AGENT IDE
Author(s): Robert Yeh Added: 5 months ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more

Intervention
EuroPCR 22: EASTBOURNE Registry indicates Satefy of Sirolimus-Coated Balloon
Author(s): Bernardo Cortese Added: 1 year ago
Dr Bernardo Cortese (La Fondazione Ricerca e Innovazione Cardiovascolare, IT) discusses the findings from the EASTBOURNE Registry, a study that investigated the sirolimus-coated balloon in an all-comer population. Findings are positive in regard to the device's safety and efficacy profile, with no safety signals for bleeding and the primary endpoint of target lesion revascularization (TLR), was… View more

Intervention
ACC.24: The SMART Trial
Author(s): Howard C Herrmann Added: 1 week ago
ACC.24 — Investigator, Dr Howard C Hermann (Penn Medicine, Philadelphia, PA, US) joins us to discuss the findings from the SMART Trial (NCT04722250).This prospective, multi-center, randomized controlled study aims to investigate the valve safety and performance of self expanding as compared to balloon-expandable transcatheter aortic valve replacement (TAVR) in patients with small aortic annuli… View more

Intervention
EuroPCR 22: Balloon Vs Self-Expanding Valves in Valve-in-Valve TAVI
Author(s): Josep Rodés-Cabau Added: 1 year ago
In this short interview, Dr Josep Rodés-Cabau (Laval University, CA) shares the findings from a study comparing balloon and self-expanding valves in valve-in-valve TAVI. Discussion Points: 1. Study Rationale 2. Study Design & Patient Selection Criteria? 3. Key Findings 4. Take-Home Messages for Practice 5. Next Steps Recorded at EuroPCR 22, Paris. Interviewer: Jonathan McKenna Videographer:… View more

Intervention